70,304 Shares in PetMed Express, Inc. (NASDAQ:PETS) Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of PetMed Express, Inc. (NASDAQ:PETS) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 70,304 shares of the company’s stock, valued at approximately $295,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.34% of PetMed Express as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Geode Capital Management LLC grew its position in PetMed Express by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 224,788 shares of the company’s stock valued at $1,084,000 after purchasing an additional 3,558 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of PetMed Express by 2.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 216,812 shares of the company’s stock worth $1,045,000 after buying an additional 4,410 shares in the last quarter. American Century Companies Inc. lifted its stake in shares of PetMed Express by 15.3% in the fourth quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock worth $162,000 after buying an additional 4,459 shares in the last quarter. Squarepoint Ops LLC grew its holdings in shares of PetMed Express by 41.4% during the fourth quarter. Squarepoint Ops LLC now owns 17,686 shares of the company’s stock valued at $85,000 after buying an additional 5,180 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of PetMed Express by 13.2% during the fourth quarter. Northern Trust Corp now owns 51,116 shares of the company’s stock valued at $246,000 after acquiring an additional 5,953 shares in the last quarter. 73.33% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Morgan Stanley decreased their price objective on shares of PetMed Express from $3.50 to $3.20 and set an “underweight” rating for the company in a report on Thursday, April 17th. Wall Street Zen cut PetMed Express from a “hold” rating to a “sell” rating in a research note on Sunday.

PetMed Express Stock Down 1.2%

Shares of NASDAQ PETS opened at $3.20 on Tuesday. The firm’s 50-day moving average price is $3.50 and its 200-day moving average price is $3.84. PetMed Express, Inc. has a 52-week low of $2.90 and a 52-week high of $6.85. The company has a market cap of $66.11 million, a PE ratio of 320.32 and a beta of 0.82.

Insiders Place Their Bets

In related news, major shareholder Silvercape Investments Ltd bought 118,200 shares of the company’s stock in a transaction that occurred on Friday, August 1st. The shares were bought at an average price of $3.21 per share, for a total transaction of $379,422.00. Following the completion of the acquisition, the insider owned 2,478,696 shares of the company’s stock, valued at $7,956,614.16. This trade represents a 5.01% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have purchased a total of 177,684 shares of company stock worth $574,320 in the last 90 days. 1.10% of the stock is owned by corporate insiders.

PetMed Express Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.